199201015575 (247079-M)
General Line
+603-2681 6222
General Line
+603-2681 6222
General Email
marketing@kpjhealth.com.my
WhatsApp
WhatsApp
Public
Corporate
en
enHealth Packages
Back to Health Packages
Back to Health Packages
Infant RSV Monoclonal Antibody Package
KPJ Sentosa KL Specialist Hospital
MYR 2,188.00
Safeguard Your Baby's Lungs During Their Most Vulnerable Months.
Respiratory Syncytial Virus (RSV) is one of the leading causes of serious lung infections and emergency hospitalisations in infants under 1 year old. At KPJ Sentosa KL Specialist Hospital, our Infant RSV Monoclonal Antibody Package provides immediate, targeted immunity directly to your baby—substantially lowering the risk of severe complications, bronchiolitis, and pneumonia.
What Is RSV & Why Are Infants at High Risk?
Respiratory Syncytial Virus (RSV) is a common virus affecting the chest and breathing passages. While adults often experience it as a mild cold, RSV poses a major risk to babies because their airways are extremely small and their immune systems are still developing.
Leading Cause of Infant Bronchiolitis:
RSV causes inflammation and heavy mucus buildup in small lung airways, leading to severe wheezing and breathing difficulty.
RSV causes inflammation and heavy mucus buildup in small lung airways, leading to severe wheezing and breathing difficulty.
Risk of Hospitalisation:
Infants in their first 6–12 months face the highest probability of needing pediatric hospital admission or oxygen support due to RSV.
Infants in their first 6–12 months face the highest probability of needing pediatric hospital admission or oxygen support due to RSV.
Immediate Protection via Monoclonal Antibodies:
Unlike traditional vaccines that require weeks for a baby's immune system to respond, monoclonal antibodies deliver ready-made protective antibodies straight to your baby's system for immediate defence.
Unlike traditional vaccines that require weeks for a baby's immune system to respond, monoclonal antibodies deliver ready-made protective antibodies straight to your baby's system for immediate defence.
Who Should Receive This Immunisation?
Newborns & Young Infants:
Babies entering or born during their first RSV season.
Babies entering or born during their first RSV season.
Infants Unprotected During Pregnancy:
Babies whose mothers did not receive the maternal RSV vaccine during the third trimester.
Babies whose mothers did not receive the maternal RSV vaccine during the third trimester.
High-Risk Infants:
Babies born prematurely or those with underlying heart, lung, or health conditions.
Babies born prematurely or those with underlying heart, lung, or health conditions.
Key Benefits for Your Baby
Immediate Passive Immunity:
Direct administration provides instant antibody coverage without relying on an immature immune system to produce antibodies.
Direct administration provides instant antibody coverage without relying on an immature immune system to produce antibodies.
Significantly Reduces Hospitalisation:
Clinical studies show monoclonal antibodies substantially reduce emergency room visits and hospital admissions for infant RSV.
Clinical studies show monoclonal antibodies substantially reduce emergency room visits and hospital admissions for infant RSV.
Supports Healthy Early Development:
Protects your baby’s breathing passages during their critical growth period.
Protects your baby’s breathing passages during their critical growth period.
Infant RSV Monoclonal Antibody Package @ RM2,188.00
Comprehensive preventive care tailored for babies.
Dosing & Weight Options
| Package Tier | Weight Criteria | Dosage |
| Infant Option A | Babies weighing less than 5 kg | 50 mg dose |
| Infant Option B | Babies weighing 5 kg and above | 100 mg dose |
.webp)
Kindly schedule your appointment via our General Paediatrics Clinic at KPJ Sentosa KL Specialist Hospital:
Package Inclusions:
1. Registration Fee: Included with no hidden charges.
2. RSV Monoclonal Antibody Administration: Single-dose administration by qualified healthcare professionals (50mg or 100mg formulation depending on weight).
3. Pre-Procedure Pediatric Evaluation: Assessment by a doctor to confirm clinical suitability and weight measurement.
Terms & Conditions
-
By Appointment Only: Prior booking is required through our Pediatric Clinic or Health Screening Unit.
-
Clinical Eligibility: Eligibility and correct dosage determination will be evaluated by the attending doctor based on your baby's weight and clinical history.
-
Excluded Costs: Consultation fees, additional diagnostic tests, medications, or specialised pediatric treatments outside the standard procedure are charged separately.
-
Self-Paying Patients: Applicable to self-paying/cash-paying patients only.
-
Price Validity: Package prices and contents are subject to change without prior notice.
Frequently Asked Questions (FAQ)
How is a monoclonal antibody different from a traditional vaccine?
Traditional vaccines stimulate an infant's own immune system to slowly build antibodies over several weeks. In contrast, a monoclonal antibody delivers ready-made, laboratory-crafted antibodies directly into your baby's bloodstream, giving them immediate protection against RSV without having to rely on an immature immune system.
How long does the protection last, and when should my baby receive it?
A single injection provides continuous protection for at least 5 months, which covers a typical RSV season. It is recommended for infants under 8 months old entering their first RSV season or shortly after birth.
Is it safe for young infants, and what are the common side effects?
Yes, clinical trials confirm it is safe and effective at preventing severe illness and hospitalisation. Side effects are typically mild and short-lived, most commonly including a minor rash or temporary redness, swelling, and soreness at the thigh injection site.
Protect Your Baby's Breathing from Day One
Give your infant direct defence against severe chest infections and hospitalisation.
Have questions or ready to schedule your appointment?
.webp)
Infant RSV Monoclonal Antibody Package
KPJ Sentosa KL Specialist Hospital
MYR 2,188.00
Book Package
Add to Cart
Infant RSV Monoclonal Antibody Package
Safeguard Your Baby's Lungs During Their Most Vulnerable Months.
Respiratory Syncytial Virus (RSV) is one of the leading causes of serious lung infections and emergency hospitalisations in infants under 1 year old. At KPJ Sentosa KL Specialist Hospital, our Infant RSV Monoclonal Antibody Package provides immediate, targeted immunity directly to your baby—substantially lowering the risk of severe complications, bronchiolitis, and pneumonia.
What Is RSV & Why Are Infants at High Risk?
Respiratory Syncytial Virus (RSV) is a common virus affecting the chest and breathing passages. While adults often experience it as a mild cold, RSV poses a major risk to babies because their airways are extremely small and their immune systems are still developing.
Leading Cause of Infant Bronchiolitis:
RSV causes inflammation and heavy mucus buildup in small lung airways, leading to severe wheezing and breathing difficulty.
RSV causes inflammation and heavy mucus buildup in small lung airways, leading to severe wheezing and breathing difficulty.
Risk of Hospitalisation:
Infants in their first 6–12 months face the highest probability of needing pediatric hospital admission or oxygen support due to RSV.
Infants in their first 6–12 months face the highest probability of needing pediatric hospital admission or oxygen support due to RSV.
Immediate Protection via Monoclonal Antibodies:
Unlike traditional vaccines that require weeks for a baby's immune system to respond, monoclonal antibodies deliver ready-made protective antibodies straight to your baby's system for immediate defence.
Unlike traditional vaccines that require weeks for a baby's immune system to respond, monoclonal antibodies deliver ready-made protective antibodies straight to your baby's system for immediate defence.
Who Should Receive This Immunisation?
Newborns & Young Infants:
Babies entering or born during their first RSV season.
Babies entering or born during their first RSV season.
Infants Unprotected During Pregnancy:
Babies whose mothers did not receive the maternal RSV vaccine during the third trimester.
Babies whose mothers did not receive the maternal RSV vaccine during the third trimester.
High-Risk Infants:
Babies born prematurely or those with underlying heart, lung, or health conditions.
Babies born prematurely or those with underlying heart, lung, or health conditions.
Key Benefits for Your Baby
Immediate Passive Immunity:
Direct administration provides instant antibody coverage without relying on an immature immune system to produce antibodies.
Direct administration provides instant antibody coverage without relying on an immature immune system to produce antibodies.
Significantly Reduces Hospitalisation:
Clinical studies show monoclonal antibodies substantially reduce emergency room visits and hospital admissions for infant RSV.
Clinical studies show monoclonal antibodies substantially reduce emergency room visits and hospital admissions for infant RSV.
Supports Healthy Early Development:
Protects your baby’s breathing passages during their critical growth period.
Protects your baby’s breathing passages during their critical growth period.
Infant RSV Monoclonal Antibody Package @ RM2,188.00
Comprehensive preventive care tailored for babies.
Dosing & Weight Options
| Package Tier | Weight Criteria | Dosage |
| Infant Option A | Babies weighing less than 5 kg | 50 mg dose |
| Infant Option B | Babies weighing 5 kg and above | 100 mg dose |
Kindly schedule your appointment via our General Paediatrics Clinic at KPJ Sentosa KL Specialist Hospital:
Package Inclusions:
1. Registration Fee: Included with no hidden charges.
2. RSV Monoclonal Antibody Administration: Single-dose administration by qualified healthcare professionals (50mg or 100mg formulation depending on weight).
3. Pre-Procedure Pediatric Evaluation: Assessment by a doctor to confirm clinical suitability and weight measurement.
Terms & Conditions
By Appointment Only: Prior booking is required through our Pediatric Clinic or Health Screening Unit.
Clinical Eligibility: Eligibility and correct dosage determination will be evaluated by the attending doctor based on your baby's weight and clinical history.
Excluded Costs: Consultation fees, additional diagnostic tests, medications, or specialised pediatric treatments outside the standard procedure are charged separately.
Self-Paying Patients: Applicable to self-paying/cash-paying patients only.
Price Validity: Package prices and contents are subject to change without prior notice.
Frequently Asked Questions (FAQ)
How is a monoclonal antibody different from a traditional vaccine?
Traditional vaccines stimulate an infant's own immune system to slowly build antibodies over several weeks. In contrast, a monoclonal antibody delivers ready-made, laboratory-crafted antibodies directly into your baby's bloodstream, giving them immediate protection against RSV without having to rely on an immature immune system.
How long does the protection last, and when should my baby receive it?
A single injection provides continuous protection for at least 5 months, which covers a typical RSV season. It is recommended for infants under 8 months old entering their first RSV season or shortly after birth.
Is it safe for young infants, and what are the common side effects?
Yes, clinical trials confirm it is safe and effective at preventing severe illness and hospitalisation. Side effects are typically mild and short-lived, most commonly including a minor rash or temporary redness, swelling, and soreness at the thigh injection site.
Protect Your Baby's Breathing from Day One
Give your infant direct defence against severe chest infections and hospitalisation.
Have questions or ready to schedule your appointment?
Our Doctors
.png)
Appointment
.png)
Appointment
.png)
Appointment
Our Doctors
Learn More
Appointment
Appointment
Appointment
Appointment
Appointment
Appointment
Appointment
Other Health Packages
Other Health Packages
Our Businesses
KKLIU
PDPA
T&C
Quick Links
Corporate
Our Businesses
KKLIU
PDPA
T&C
